Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.20
- Piotroski Score 3.00
- Grade Neutral
- Symbol (IZEA)
- Company IZEA Worldwide, Inc.
- Price $2.59
- Changes Percentage (-1.52%)
- Change -$0.04
- Day Low $2.46
- Day High $2.61
- Year High $3.60
IZEA Worldwide, Inc., together with its subsidiaries, creates and operates online marketplaces that connect marketers and content creators. Its technology solutions enable the management of content workflow, creator search and targeting, bidding, analytics, and payment processing. The company uses its platform to manage influencer marketing campaigns on behalf of the company's marketers. It primarily sells influencer marketing and custom content campaigns through sales team and platforms, as well as IZEA Exchange BrandGraph, and Shake platforms. The company was formerly known as IZEA, Inc. and changed its name to IZEA Worldwide, Inc. in August 2018. IZEA Worldwide, Inc. was founded in 2006 and is headquartered in Orlando, Florida.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.47
- Trailing P/E Ratio -4.89
- Forward P/E Ratio -4.89
- P/E Growth -4.89
- Net Income $-7,349,360
Income Statement
Quarterly
Annual
Latest News of IZEA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Industry Analysts Just Made A Sizeable Upgrade To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Revenue Forecasts
Iovance Biotherapeutics (NASDAQ:IOVA) saw significant upgrades in revenue forecasts, with analysts predicting a 396% increase by 2024. Share price surged 36% in 7 days. Analysts expect accelerated gro...
By Yahoo! Finance | 1 month ago -
W&T Offshore, Inc. (NYSE:WTI) has caught the attention of institutional investors who hold a sizeable 39% stake
A majority stake in W&T Offshore, Inc. is held by 7 investors with 51% ownership. Institutional investors own 39% of the company, showing confidence in its future. CEO Tracy Krohn is the largest share...
By Yahoo! Finance | 1 month ago -
The Joint Corp. (NASDAQ:JYNT) has caught the attention of institutional investors who hold a sizeable 48% stake
Analyzing analyst forecasts and ownership data can aid in evaluating a company's future performance. Institutional ownership, like in The Joint Corp. (NASDAQ:JYNT), influences stock movement and refle...
By Yahoo! Finance | 1 month ago
